Franklin Salisbury's most recent trade in CASI Pharmaceuticals Inc was a trade of 388,387 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 25, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CASI Pharmaceuticals Inc | Franklin C. Salisbury | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 388,387 | 388,387 | - | - | Stock Option (Right to Buy) | |
| CASI Pharmaceuticals Inc | Franklin C. Salisbury | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 110,459 | 110,459 | - | - | Stock Option (Right to Buy) |